Form EFFECT Cadrenal Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 20, 2024 5:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Positive Development Expands Its Developmental Therapy Services to Families in South Carolina
- StrongMind Unveils StrongMind CoursePro, an AI-Powered Course Creation Platform, at DLAC Ignite
- Personal AI Launches MODEL‑4, Building Personal Intelligence Directly Into the Network
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share